Qilu Pharmaceutical Research and Development Centre

Qilu Pharmaceutical is a leading vertically integrated Chinese pharmaceutical company engaged in the development, manufacturing, and commercialization of generic and innovative drugs. The company's R&D efforts focus on oncology, cardiovascular, infectious diseases, and CNS disorders, with a robust pipeline of small molecules, biologics, and biosimilars. With a global footprint including R&D centers in the United States and China, Qilu has successfully launched numerous products internationally, including the first Chinese-made biosimilar approved in several major markets. They operate extensive manufacturing facilities that meet global GMP standards, supporting both their internal portfolio and CDMO services. The company is recognized for its rapid transition from a traditional generics manufacturer to an innovation-driven biopharmaceutical leader.